Table 1.
Comparison between responders (n = 63) and nonresponders (n = 49) in patient demographics and medications prescribed alongside exenatide. Results are presented as the mean ± SD for continuous variables and as the number (plus percentage) for categorical variables.
| Variable | Group | P value | |
|---|---|---|---|
| Responders | Nonresponders | ||
| Gender male (% male) | 36 (57) | 28 (57) | 1.00 |
| Age | 59 ± 11 | 61 ± 10 | 0.16 |
| Duration of T2DM in years | 14 ± 6.06 | 14.9 ± 5.83 | 0.40 |
| Prescribed exenatide only (%) | 5 (7.94) | 2 (4.08) | 0.46 |
| Prescribed exenatide with OHAs only (%) | 45 (71.4) | 27 (55.1) | 0.11 |
| Prescribed exenatide with insulin only (%) | 2 (3.17) | 10 (20.4) | 0.0047 |
| Prescribed exenatide with OHAs and insulin (%) | 11 (17.5) | 10 (20.4) | 0.88 |
OHA: oral antihyperglycaemic agent; T2DM: type 2 diabetes mellitus.